Pharmaceutical | Tokio X'press - Part 40

Massive WHO remdesivir study suggests no Covid-19 benefit

Thursday October 22nd, 2020By Tokio X'press flu, FDA, Pharmaceutical

COVID-19: EU, Remdesivir supply contract: need to be reviewed?

Thursday October 22nd, 2020By Tokio X'press flu, FDA, Pharmaceutical

COVID-19: Utilizing iPS cells: Fujita Medical University and Rebirthel

Wednesday October 21st, 2020By Tokio X'press flu, Medical science, Pharmaceutical

COVID-19: Takeda Pharmaceutical, immunoglobulin clinical trial started: 500 participants from 18 countries

Friday October 16th, 2020By Tokio X'press flu, Pharmaceutical

COVID-19: Chugai’s Actemra: Roche, 3P start in the world

Thursday October 15th, 2020By Tokio X'press flu, Pharmaceutical

1 … 39 40 41 … 111